AdvisorNet Financial Inc Has $1.52 Million Position in CVS Health Corp (NYSE:CVS)
AdvisorNet Financial Inc grew its holdings in CVS Health Corp (NYSE:CVS) by 32.6% during the second quarter, Holdings Channel.com reports. The firm owned 23,416 shares of the pharmacy operator’s stock after acquiring an additional 5,752 shares during the period. AdvisorNet Financial Inc’s holdings in CVS Health were worth $1,521,000 at the end of the most recent reporting period.
A number of other institutional investors have also bought and sold shares of the business. Hoover Financial Advisors Inc. bought a new stake in shares of CVS Health during the second quarter worth $32,000. Exchange Traded Concepts LLC bought a new stake in CVS Health in the second quarter valued at about $41,000. Keebeck Wealth Management LLC bought a new stake in CVS Health in the second quarter valued at about $42,000. Balentine LLC bought a new stake in shares of CVS Health in the first quarter worth about $47,000. Finally, Campbell Wealth Management bought a new stake in shares of CVS Health in the second quarter worth about $49,000. 75.88% of the stock is currently owned by institutional investors.
CVS has been the subject of several recent analyst reports. Credit Suisse Group increased their price target on CVS Health from $75.00 to $90.00 and gave the stock an “outperform” rating in a report on Friday, August 7th. Royal Bank of Canada reaffirmed a “buy” rating on shares of CVS Health in a research report on Thursday, July 9th. Deutsche Bank reduced their price objective on CVS Health from $109.00 to $104.00 and set a “buy” rating for the company in a research report on Thursday, August 6th. Finally, SVB Leerink upped their price objective on CVS Health from $72.00 to $73.00 and gave the stock a “market perform” rating in a research report on Thursday, August 6th. One analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $82.60.
CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.64 EPS for the quarter, topping the Zacks’ consensus estimate of $1.93 by $0.71. CVS Health had a return on equity of 16.32% and a net margin of 3.13%. The firm had revenue of $65.30 billion for the quarter, compared to analyst estimates of $64.29 billion. During the same quarter last year, the company earned $1.89 EPS. The company’s revenue was up 2.9% on a year-over-year basis. Sell-side analysts anticipate that CVS Health Corp will post 7.23 earnings per share for the current year.
CVS Health Company Profile
CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.
Featured Story: Marijuana Stocks Investing Considerations
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.